review glp-1 Cardiovascular Effects and Tolerability of Receptor Agonists: A Systematic and Meta-Analysis of 99,599 Patients GLP-1 agonists and changes in

The orexigenic action of ghrelin is mediated through direct stimulation of the orexigenic AgRP/NPY neurons and concomitant inhibition of the anorectic POMC/CART neurons in the ARC (143, 144)

However, recent research has raised questions about whether some GLP-1 medications, especially semaglutide, may be associated with a higher risk of a rare but serious eye condition called NAION

IGF-1 levels : Periodic monitoring (every 36 months) when using sermorelin to ensure physiological rather than supraphysiological growth hormone stimulation

People need to know from the start that these are prescribed as long-term medications for their effect on body weight, glucose levels, and potentially cardiovascular protection, Pratley says, adding that people dont stop antihypertensives or statins because they achieve or reach normal blood pressure or LDL cholesterol levels, respectively

This might trigger the body to release GLP-1, aiding in appetite regulation and potentially supporting weight loss efforts